Detalhe da pesquisa
1.
Ultracompact metalens-based beam-focusing fiber-optic device with a large numerical aperture.
Opt Lett
; 48(7): 1742-1745, 2023 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37221755
2.
Compact magnetic field sensor based on plasmonic fiber-tip.
Opt Express
; 29(23): 38904-38914, 2021 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34808933
3.
Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma.
Blood
; 122(4): 499-506, 2013 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-23692856
4.
Rupture Risk Assessment of Cervical Spinal Manipulations on Carotid Atherosclerotic Plaque by a 3D Fluid-Structure Interaction Model.
Biomed Res Int
; 2021: 8239326, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33490277
5.
Virologic response and safety of the abacavir/lamivudine fixed-dose formulation as part of highly active antiretroviral therapy: analyses of six clinical studies.
HIV Clin Trials
; 10(2): 65-75, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19487176
6.
Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT.
AIDS Res Ther
; 5: 5, 2008 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-18373851
7.
Prevalence of antiretroviral drug resistance and resistance-associated mutations in antiretroviral therapy-naïve HIV-infected individuals from 40 United States cities.
HIV Clin Trials
; 8(1): 1-8, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17434843
8.
Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study.
J Clin Oncol
; 35(5): 544-551, 2017 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28029326
9.
Once-weekly ofatumumab in untreated or relapsed Waldenström's macroglobulinaemia: an open-label, single-arm, phase 2 study.
Lancet Haematol
; 4(1): e24-e34, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27914971
10.
Fosamprenavir clinical study meta-analysis in ART-naïve subjects: rare occurrence of virologic failure and selection of protease-associated mutations.
HIV Clin Trials
; 7(6): 334-8, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17197380
11.
Pilot study of once-daily simplification therapy with abacavir/lamivudine/zidovudine and efavirenz for treatment of HIV-1 infection.
HIV Clin Trials
; 7(5): 229-36, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17162316
12.
Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens.
BMC Infect Dis
; 5: 23, 2005 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-15819974
13.
Genotypic and phenotypic cross-resistance patterns to lopinavir and amprenavir in protease inhibitor-experienced patients with HIV viremia.
AIDS Res Hum Retroviruses
; 18(14): 1011-9, 2002 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-12396453
14.
Pharmacodynamic effects of zidovudine 600 mg once/day versus 300 mg twice/day in therapy-naïve patients infected with human immunodeficiency virus.
Pharmacotherapy
; 24(3): 307-12, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15040643
15.
Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients.
BMC Infect Dis
; 3: 10, 2003 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-12795812
16.
Stavudine-associated peripheral neuropathy in zidovudine-naïve patients: effect of stavudine exposure and antiretroviral experience.
Adv Ther
; 19(1): 1-8, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12008857
17.
Characteristics of foot fractures in HIV-infected patients previously treated with tenofovir versus non-tenofovir-containing highly active antiretroviral therapy.
HIV AIDS (Auckl)
; 3: 53-9, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22096407
18.
Comparison of once-daily fosamprenavir boosted with either 100 or 200 mg of ritonavir, in combination with abacavir/lamivudine: 96-week results from COL100758.
AIDS Res Hum Retroviruses
; 25(4): 395-403, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19320570
19.
First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America.
AIDS
; 22(13): 1673-5, 2008 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18670229
20.
Long-term results of initial therapy with abacavir and Lamivudine combined with Efavirenz, Amprenavir/Ritonavir, or Stavudine.
J Acquir Immune Defic Syndr
; 43(3): 284-92, 2006 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16967040